Background Idiopathic pulmonary fibrosis (IPF) is the most common type of fatal interstitial
lung disease and IPF patients usually have a poor prognosis. Biomarkers that can predict …

Objective Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible, high-
mortality lung disease, but its pathogenesis is still unclear. Our purpose was to explore …

Rationale: Idiopathic pulmonary fibrosis (IPF) is one of the most aggressive forms of
idiopathic interstitial pneumonia. Some miRNAs may be associated with IPF and may affect …

Idiopathic pulmonary fibrosis (IPF) is considered to be an ailment of the lungs that cannot be
cured, wherein the lung tissues are characterized by increased thickness and stiffness …

To the Editor: Idiopathic pulmonary fibrosis (IPF) is a kind of lung disease characterized by
chronic and progressive pulmonary fibrosis with unknown etiology, whose pathological …

Idiopathic pulmonary fibrosis (IPF) is a lethal fibrotic lung disease with an increasing global
burden. It is hypothesized that fibroblasts have a number of functions that may affect the …

The progression of idiopathic pulmonary fibrosis (IPF) is diverse and unpredictable. We
identified and validated a new biomarker for IPF progression. To identify a candidate gene to …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial lung disease
of unknown etiology that is currently untreatable. In this study we aim to characterize the …

Background: Idiopathic pulmonary fibrosis (IPF) is a life-threatening disease whose etiology
remains unknown. This study aims to explore diagnostic biomarkers and pathways involved …

Idiopathic pulmonary fibrosis (IPF) remains a lethal disease with unknown etiology and
unmet medical need. The aim of this study was to perform an integrative analysis of multiple …